JAK1/2 inhibitor

Dr. Jaehyuk Choi presented his research about novel therapies for cutaneous lymphomas. In his research, Dr. Choi analyzes patient samples using omics, machine learning, and AI to identify therapeutic targets for further evaluation in clinical trials. Dr. Choi shared three patient cases where he helped the treating physician find therapies to induce remission. Case #1…